22nd Century Group to Participate in Investor Conferences in March 2021
March 05 2021 - 9:15AM
22nd Century Group, Inc. (NYSE American: XXII), a leading
plant-based, biotechnology company focused on tobacco harm
reduction, very low nicotine content tobacco, and hemp/cannabis
research, today announced that members of its management team will
participate in three investor conferences during March 2021.
Institutional investors and those invited to
attend these virtual conference events may request one-on-one
meetings with representatives of the Company through the respective
conference hosts or by contacting 22nd Century Group’s investor
relations via mkuo@xxiicentury.com.
Events 22nd Century Group will participate in include:
The DA Davidson 4th Annual Consumer Growth Conference,
March 11, 2021One-on-one meetings will be available on the
afternoon of Thursday, March 11. To request a meeting, please
contact your DA Davidson sales representative.
The 33rd Annual Roth Conference, March 15-17,
2021One-on-one and small group meetings will be available
on Tuesday, March 16. Additional times may be available to
accommodate meeting requests as needed. To request a meeting,
please contact your Roth sales representative.
The Investor Summit Virtual Conference, March 23-25,
2021James A. Mish, chief executive officer of 22nd
Century, will provide an overview presentation of the Company. An
audio webcast of the presentation will be available through 22nd
Century’s Events web page in the Company's Investor Relations
section of the website, at www.xxiicentury.com/investors/events.
One-on-one meetings will be available on Tuesday, March 23. To
request a meeting, please contact your Investor Summit Group
representative.
About 22nd Century Group, Inc.22nd Century
Group, Inc. (NYSE American: XXII) is a leading plant
biotechnology company focused on technologies that alter the level
of nicotine in tobacco plants and the level of cannabinoids in
hemp/cannabis plants through genetic engineering, gene-editing, and
modern plant breeding. 22nd Century’s primary mission in tobacco is
to reduce the harm caused by smoking through the Company’s
proprietary reduced nicotine content tobacco cigarettes –
containing 95% less nicotine than conventional cigarettes. The
Company’s primary mission in hemp/cannabis is to develop and
commercialize proprietary hemp/cannabis plants with valuable
cannabinoid profiles and desirable agronomic traits.
Learn more at xxiicentury.com, on
Twitter @_xxiicentury, and on LinkedIn.
Cautionary Note Regarding
Forward-Looking StatementsExcept for historical
information, all of the statements, expectations, and assumptions
contained in this press release are forward-looking statements.
Forward-looking statements typically contain terms such as
“anticipate,” “believe,” “consider,” “continue,” “could,”
“estimate,” “expect,” “explore,” “foresee,” “goal,” “guidance,”
“intend,” “likely,” “may,” “plan,” “potential,” “predict,”
“preliminary,” “probable,” “project,” “promising,” “seek,”
“should,” “will,” “would,” and similar expressions. Actual results
might differ materially from those explicit or implicit in
forward-looking statements. Important factors that could cause
actual results to differ materially are set forth in “Risk Factors”
in the Company’s Annual Report on Form 10-K filed on March 11,
2020, and in its subsequently filed Quarterly Report on Form 10-Q.
All information provided in this release is as of the date hereof,
and the Company assumes no obligation to and does not intend to
update these forward-looking statements, except as required by
law.
Investor Relations & Media
Contact:Mei KuoDirector, Communications & Investor
Relations22nd Century Group, Inc.(716)
300-1221mkuo@xxiicentury.com
22nd Century (AMEX:XXII)
Historical Stock Chart
From Apr 2024 to May 2024
22nd Century (AMEX:XXII)
Historical Stock Chart
From May 2023 to May 2024